Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity.
Identifieur interne : 001932 ( PubMed/Corpus ); précédent : 001931; suivant : 001933Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity.
Auteurs : M G Hemida ; R A Perera ; R A Al Jassim ; G. Kayali ; L Y Siu ; P. Wang ; K W Chu ; S. Perlman ; M A Ali ; A. Alnaeem ; Y. Guan ; L L Poon ; L. Saif ; M. PeirisSource :
- Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [ 1560-7917 ] ; 2014.
English descriptors
- KwdEn :
- Animals, Antibodies, Neutralizing (blood), Antibodies, Viral (blood), Australia (epidemiology), Camelus (blood), Cattle (blood), Coronavirus (immunology), Coronavirus (isolation & purification), Coronavirus Infections (blood), Coronavirus Infections (epidemiology), Coronavirus Infections (virology), Humans, Immunoglobulin G (blood), Neutralization Tests (methods), Prevalence, Respiratory Tract Infections (blood), Respiratory Tract Infections (epidemiology), Respiratory Tract Infections (virology), Saudi Arabia (epidemiology), Seroepidemiologic Studies.
- MESH :
- chemical , blood : Antibodies, Neutralizing, Antibodies, Viral, Immunoglobulin G.
- blood : Camelus, Cattle, Coronavirus Infections, Respiratory Tract Infections.
- epidemiology : Australia, Coronavirus Infections, Respiratory Tract Infections, Saudi Arabia.
- immunology : Coronavirus.
- isolation & purification : Coronavirus.
- methods : Neutralization Tests.
- virology : Coronavirus Infections, Respiratory Tract Infections.
- Animals, Humans, Prevalence, Seroepidemiologic Studies.
Abstract
The pseudoparticle virus neutralisation test (ppNT) and a conventional microneutralisation (MN) assay are specific for detecting antibodies to Middle East respiratory syndrome coronavirus (MERS-CoV) when used in seroepidemiological studies in animals. Genetically diverse MERS-CoV appear antigenically similar in MN tests. We confirm that MERS-CoV was circulating in dromedaries in Saudi Arabia in 1993. Preliminary data suggest that feral Australian dromedaries may be free of MERS-CoV but larger confirmatory studies are needed.
DOI: 10.2807/1560-7917.es2014.19.23.20828
PubMed: 24957744
Links to Exploration step
pubmed:24957744Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity.</title><author><name sortKey="Hemida, M G" sort="Hemida, M G" uniqKey="Hemida M" first="M G" last="Hemida">M G Hemida</name><affiliation><nlm:affiliation>These authors contributed equally to this work.</nlm:affiliation></affiliation></author><author><name sortKey="Perera, R A" sort="Perera, R A" uniqKey="Perera R" first="R A" last="Perera">R A Perera</name></author><author><name sortKey="Al Jassim, R A" sort="Al Jassim, R A" uniqKey="Al Jassim R" first="R A" last="Al Jassim">R A Al Jassim</name></author><author><name sortKey="Kayali, G" sort="Kayali, G" uniqKey="Kayali G" first="G" last="Kayali">G. Kayali</name></author><author><name sortKey="Siu, L Y" sort="Siu, L Y" uniqKey="Siu L" first="L Y" last="Siu">L Y Siu</name></author><author><name sortKey="Wang, P" sort="Wang, P" uniqKey="Wang P" first="P" last="Wang">P. Wang</name></author><author><name sortKey="Chu, K W" sort="Chu, K W" uniqKey="Chu K" first="K W" last="Chu">K W Chu</name></author><author><name sortKey="Perlman, S" sort="Perlman, S" uniqKey="Perlman S" first="S" last="Perlman">S. Perlman</name></author><author><name sortKey="Ali, M A" sort="Ali, M A" uniqKey="Ali M" first="M A" last="Ali">M A Ali</name></author><author><name sortKey="Alnaeem, A" sort="Alnaeem, A" uniqKey="Alnaeem A" first="A" last="Alnaeem">A. Alnaeem</name></author><author><name sortKey="Guan, Y" sort="Guan, Y" uniqKey="Guan Y" first="Y" last="Guan">Y. Guan</name></author><author><name sortKey="Poon, L L" sort="Poon, L L" uniqKey="Poon L" first="L L" last="Poon">L L Poon</name></author><author><name sortKey="Saif, L" sort="Saif, L" uniqKey="Saif L" first="L" last="Saif">L. Saif</name></author><author><name sortKey="Peiris, M" sort="Peiris, M" uniqKey="Peiris M" first="M" last="Peiris">M. Peiris</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24957744</idno><idno type="pmid">24957744</idno><idno type="doi">10.2807/1560-7917.es2014.19.23.20828</idno><idno type="wicri:Area/PubMed/Corpus">001932</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001932</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity.</title><author><name sortKey="Hemida, M G" sort="Hemida, M G" uniqKey="Hemida M" first="M G" last="Hemida">M G Hemida</name><affiliation><nlm:affiliation>These authors contributed equally to this work.</nlm:affiliation></affiliation></author><author><name sortKey="Perera, R A" sort="Perera, R A" uniqKey="Perera R" first="R A" last="Perera">R A Perera</name></author><author><name sortKey="Al Jassim, R A" sort="Al Jassim, R A" uniqKey="Al Jassim R" first="R A" last="Al Jassim">R A Al Jassim</name></author><author><name sortKey="Kayali, G" sort="Kayali, G" uniqKey="Kayali G" first="G" last="Kayali">G. Kayali</name></author><author><name sortKey="Siu, L Y" sort="Siu, L Y" uniqKey="Siu L" first="L Y" last="Siu">L Y Siu</name></author><author><name sortKey="Wang, P" sort="Wang, P" uniqKey="Wang P" first="P" last="Wang">P. Wang</name></author><author><name sortKey="Chu, K W" sort="Chu, K W" uniqKey="Chu K" first="K W" last="Chu">K W Chu</name></author><author><name sortKey="Perlman, S" sort="Perlman, S" uniqKey="Perlman S" first="S" last="Perlman">S. Perlman</name></author><author><name sortKey="Ali, M A" sort="Ali, M A" uniqKey="Ali M" first="M A" last="Ali">M A Ali</name></author><author><name sortKey="Alnaeem, A" sort="Alnaeem, A" uniqKey="Alnaeem A" first="A" last="Alnaeem">A. Alnaeem</name></author><author><name sortKey="Guan, Y" sort="Guan, Y" uniqKey="Guan Y" first="Y" last="Guan">Y. Guan</name></author><author><name sortKey="Poon, L L" sort="Poon, L L" uniqKey="Poon L" first="L L" last="Poon">L L Poon</name></author><author><name sortKey="Saif, L" sort="Saif, L" uniqKey="Saif L" first="L" last="Saif">L. Saif</name></author><author><name sortKey="Peiris, M" sort="Peiris, M" uniqKey="Peiris M" first="M" last="Peiris">M. Peiris</name></author></analytic><series><title level="j">Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</title><idno type="eISSN">1560-7917</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antibodies, Neutralizing (blood)</term><term>Antibodies, Viral (blood)</term><term>Australia (epidemiology)</term><term>Camelus (blood)</term><term>Cattle (blood)</term><term>Coronavirus (immunology)</term><term>Coronavirus (isolation & purification)</term><term>Coronavirus Infections (blood)</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (virology)</term><term>Humans</term><term>Immunoglobulin G (blood)</term><term>Neutralization Tests (methods)</term><term>Prevalence</term><term>Respiratory Tract Infections (blood)</term><term>Respiratory Tract Infections (epidemiology)</term><term>Respiratory Tract Infections (virology)</term><term>Saudi Arabia (epidemiology)</term><term>Seroepidemiologic Studies</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Neutralizing</term><term>Antibodies, Viral</term><term>Immunoglobulin G</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Camelus</term><term>Cattle</term><term>Coronavirus Infections</term><term>Respiratory Tract Infections</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Australia</term><term>Coronavirus Infections</term><term>Respiratory Tract Infections</term><term>Saudi Arabia</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Coronavirus</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Coronavirus</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Neutralization Tests</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term><term>Respiratory Tract Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Humans</term><term>Prevalence</term><term>Seroepidemiologic Studies</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The pseudoparticle virus neutralisation test (ppNT) and a conventional microneutralisation (MN) assay are specific for detecting antibodies to Middle East respiratory syndrome coronavirus (MERS-CoV) when used in seroepidemiological studies in animals. Genetically diverse MERS-CoV appear antigenically similar in MN tests. We confirm that MERS-CoV was circulating in dromedaries in Saudi Arabia in 1993. Preliminary data suggest that feral Australian dromedaries may be free of MERS-CoV but larger confirmatory studies are needed.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24957744</PMID><DateCompleted><Year>2014</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1560-7917</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>23</Issue><PubDate><Year>2014</Year><Month>Jun</Month><Day>12</Day></PubDate></JournalIssue><Title>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</Title><ISOAbbreviation>Euro Surveill.</ISOAbbreviation></Journal><ArticleTitle>Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">20828</ELocationID><Abstract><AbstractText>The pseudoparticle virus neutralisation test (ppNT) and a conventional microneutralisation (MN) assay are specific for detecting antibodies to Middle East respiratory syndrome coronavirus (MERS-CoV) when used in seroepidemiological studies in animals. Genetically diverse MERS-CoV appear antigenically similar in MN tests. We confirm that MERS-CoV was circulating in dromedaries in Saudi Arabia in 1993. Preliminary data suggest that feral Australian dromedaries may be free of MERS-CoV but larger confirmatory studies are needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hemida</LastName><ForeName>M G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>These authors contributed equally to this work.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perera</LastName><ForeName>R A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Al Jassim</LastName><ForeName>R A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Kayali</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Siu</LastName><ForeName>L Y</ForeName><Initials>LY</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>K W</ForeName><Initials>KW</Initials></Author><Author ValidYN="Y"><LastName>Perlman</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Alnaeem</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Poon</LastName><ForeName>L L</ForeName><Initials>LL</Initials></Author><Author ValidYN="Y"><LastName>Saif</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Peiris</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HHSN266200700005C</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AI060699</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI091322</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN266200700005C</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Sweden</Country><MedlineTA>Euro Surveill</MedlineTA><NlmUniqueID>100887452</NlmUniqueID><ISSNLinking>1025-496X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N">Australia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002162" MajorTopicYN="N">Camelus</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017934" MajorTopicYN="N">Coronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012529" MajorTopicYN="N">Saudi Arabia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24957744</ArticleId><ArticleId IdType="pmc">PMC4674219</ArticleId><ArticleId IdType="mid">NIHMS741622</ArticleId><ArticleId IdType="doi">10.2807/1560-7917.es2014.19.23.20828</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nat Med. 2004 Dec;10(12 Suppl):S88-97</Citation><ArticleIdList><ArticleId IdType="pubmed">15577937</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1982 Sep;37(3):1148-55</Citation><ArticleIdList><ArticleId IdType="pubmed">6182101</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2009 May;45(1):54-60</Citation><ArticleIdList><ArticleId IdType="pubmed">19342289</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Microbiol Immunol. 2009 Aug;198(3):157-74</Citation><ArticleIdList><ArticleId IdType="pubmed">19529959</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2013 Oct;13(10):859-66</Citation><ArticleIdList><ArticleId IdType="pubmed">23933067</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2013;18(36):pii=20574</Citation><ArticleIdList><ArticleId IdType="pubmed">24079378</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Top Microbiol Immunol. 2013;365:281-98</Citation><ArticleIdList><ArticleId IdType="pubmed">22903569</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2013;18(50):20662</Citation><ArticleIdList><ArticleId IdType="pubmed">24342516</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2013;18(50):20659</Citation><ArticleIdList><ArticleId IdType="pubmed">24342517</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2014 Feb;14(2):140-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24355866</ArticleId></ArticleIdList></Reference><Reference><Citation>MBio. 2014;5(2):e00884-14</Citation><ArticleIdList><ArticleId IdType="pubmed">24570370</ArticleId></ArticleIdList></Reference><Reference><Citation>Transbound Emerg Dis. 2014 Apr;61(2):105-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24456414</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2014 Apr;20(4):552-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24655412</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2014 Jun;20(6):1049-53</Citation><ArticleIdList><ArticleId IdType="pubmed">24856660</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2014 Jun;20(6):1012-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24857749</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2014 Jul;20(7):1231-4</Citation><ArticleIdList><ArticleId IdType="pubmed">24964193</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2014 Aug;20(8):1370-4</Citation><ArticleIdList><ArticleId IdType="pubmed">25062254</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2014 Aug;20(8):1319-22</Citation><ArticleIdList><ArticleId IdType="pubmed">25075637</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2004 Jun;10(6):1030-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15207054</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2007 Nov;40(3):207-13</Citation><ArticleIdList><ArticleId IdType="pubmed">17889596</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001932 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001932 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:24957744
|texte= Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:24957744" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |